美国医院脓毒症与阿片类药物相关住院的流行病学、结局与趋势
该回顾性队列研究纳入2009年1月至2015年9月约373家美国医院的6,715,286例成人住院,其中脓毒症375,479例(5.6%),阿片相关住院130,399例(1.9%),两者兼有8,764例(0.1%)。与无阿片相关住院的脓毒症患者相比,阿片相关脓毒症患者更年轻(平均52.3 vs 66.9岁)、合并症更少(Elixhauser评分5.4 vs 10.5)、革兰阳性菌和真菌血流感染更多(68.9% vs 47.0%;10.6% vs 6.4%),院内病死率更低(10.6% vs 16.2%;aOR 0.73,95%CI 0.60-0.79,P<0.001)。阿片相关住院死亡患者中51.5%合并脓毒症,阿片相关住院占全部脓毒症相关死亡的1.5%,占50岁以下脓毒症死亡的5.7%;2009-2015年脓毒症住院中阿片相关比例增加77%(95%CI 40.7-123.5%)。
要点
- 阿片相关住院的脓毒症患者更年轻(平均52.3岁)、合并症更少(Elixhauser 5.4),但革兰阳性菌(68.9%)和真菌(10.6%)血流感染比例更高。
- 阿片相关脓毒症患者院内病死率低于无阿片相关者(10.6% vs 16.2%),校正后aOR 0.73(95%CI 0.60-0.79,P<0.001)。
- 阿片相关住院死亡者中51.5%合并脓毒症;阿片相关住院占全部脓毒症相关死亡的1.5%,占<50岁脓毒症死亡的5.7%。
- 2009-2015年脓毒症住院中阿片相关比例增加77%(95%CI 40.7-123.5%),提示阿片人群脓毒症负担上升。
- 脓毒症识别基于同时存在感染和器官功能障碍的临床指标,阿片相关住院基于ICD-9-CM编码和/或丁丙诺啡住院医嘱。
适用人群与场景
- 2009年1月至2015年9月入住约373家美国医院的成人患者。
- 脓毒症患者按是否合并阿片相关住院分组比较;原文未提及排除人群。
诊断标准与关键阈值
- 脓毒症:由同时存在感染和器官功能障碍的临床指标识别(原文未给出具体指标或界值)。
- 阿片相关住院:由ICD-9-CM编码和/或丁丙诺啡住院医嘱识别。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 回顾性队列研究,约373家美国医院,6,715,286例成人住院;脓毒症375,479例(5.6%),阿片相关住院130,399例(1.9%),两者兼有8,764例(0.1%)。
- 阿片相关脓毒症 vs 无阿片相关脓毒症:更年轻(平均52.3 vs 66.9岁)、Elixhauser评分更低(5.4 vs 10.5)、革兰阳性菌血流感染更多(68.9% vs 47.0%)、真菌血流感染更多(10.6% vs 6.4%)。
- 主要终点院内病死率:阿片相关脓毒症10.6% vs 无阿片相关16.2%,校正后aOR 0.73(95%CI 0.60-0.79,P<0.001)。
- 阿片相关住院死亡1,803例中928例(51.5%)合并脓毒症;阿片相关住院占全部脓毒症相关死亡的1.5%,占<50岁脓毒症死亡的5.7%。
- 2009-2015年脓毒症住院中阿片相关比例增加77%(95%CI 40.7-123.5%)。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:观察性设计,脓毒症与阿片相关住院均基于编码/医嘱识别,可能存在错分;原文未给出证据等级或推荐强度。
对床旁实践的改变
- 对阿片相关住院患者应警惕脓毒症,尤其年轻患者;该人群革兰阳性菌和真菌血流感染比例更高,经验性抗感染覆盖需考虑。
- 阿片相关脓毒症病死率相对较低,但仍是重要死因,不能因年轻、合并症少而低估病情。
- 2009-2015年脓毒症住院中阿片相关比例增加77%,提示需在阿片使用人群中加强脓毒症识别与宣教。
指南或共识出处
- 原文未提及指南或共识;研究发表于Crit Care Med。
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Widespread use and misuse of prescription and illicit opioids have exposed millions to health risks including serious infectious complications. Little is known, however, about the association between opioid use and sepsis.
DESIGN: Retrospective cohort study.
SETTING: About 373 U.S. hospitals.
PATIENTS: Adults hospitalized between January 2009 and September 2015.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Sepsis was identified by clinical indicators of concurrent infection and organ dysfunction. Opioid-related hospitalizations were identified by the International Classification of Diseases, 9th Revision, Clinical Modification codes and/or inpatient orders for buprenorphine. Clinical characteristics and outcomes were compared by sepsis and opioid-related hospitalization status. The association between opioid-related hospitalization and all-cause, in-hospital mortality in patients with sepsis was assessed using mixed-effects logistic models to adjust for baseline characteristics and severity of illness.The cohort included 6,715,286 hospitalizations; 375,479 (5.6%) had sepsis, 130,399 (1.9%) had opioid-related hospitalizations, and 8,764 (0.1%) had both. Compared with sepsis patients without opioid-related hospitalizations (n = 366,715), sepsis patients with opioid-related hospitalizations (n = 8,764) were younger (mean 52.3 vs 66.9 yr) and healthier (mean Elixhauser score 5.4 vs 10.5), had more bloodstream infections from Gram-positive and fungal pathogens (68.9% vs 47.0% and 10.6% vs 6.4%, respectively), and had lower in-hospital mortality rates (10.6% vs 16.2%; adjusted odds ratio, 0.73; 95% CI, 0.60-0.79; p < 0.001 for all comparisons). Of 1,803 patients with opioid-related hospitalizations who died in-hospital, 928 (51.5%) had sepsis. Opioid-related hospitalizations accounted for 1.5% of all sepsis-associated deaths, including 5.7% of sepsis deaths among patients less than 50 years old. From 2009 to 2015, the proportion of sepsis hospitalizations that were opioid-related increased by 77% (95% CI, 40.7-123.5%).
CONCLUSIONS: Sepsis is an important cause of morbidity and mortality in patients with opioid-related hospitalizations, and opioid-related hospitalizations contribute disproportionately to sepsis-associated deaths among younger patients. In addition to ongoing efforts to combat the opioid crisis, public health agencies should focus on raising awareness about sepsis among patients who use opioids and their providers.
参考来源
- Alrawashdeh M, Klompas M, Kimmel S, et al. Epidemiology, Outcomes, and Trends of Patients With Sepsis and Opioid-Related Hospitalizations in U.S. Hospitals. Crit Care Med. 2021. PMID: 34314131. doi:10.1097/CCM.0000000000005141
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。